evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Adjunctive couple or family therapy vs structured or non‐specific individual therapy alone

Dropout · post‐traumatic stress disorder (PTSD)

Adjunctive couple or family therapy showed no clear difference in treatment dropout (treatment acceptability) compared with structured or non‐specific individual therapy alone (low certainty).

1 finding from 1 review

Timer watch plus standard urotherapy vs urotherapy alone

Resolution of daytime urinary incontinence · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week

It is very uncertain whether timer watch plus standard urotherapy changes resolution of daytime urinary incontinence after 3 months of treatment compared with standard urotherapy alone (very low certainty).

1 finding from 1 review

Timer watch plus standard urotherapy vs urotherapy alone

Frequency of incontinence episodes · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week

It is very uncertain whether timer watch plus standard urotherapy changes frequency of incontinence episodes at 3 months compared with standard urotherapy alone (very low certainty).

1 finding from 1 review

Timer watch plus standard urotherapy vs urotherapy alone

Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐EGFR antibody plus chemotherapy vs chemotherapy alone

Grade 3 to 4 diarrhoea · treatment of relapsed epithelial ovarian cancer

It is very uncertain whether anti‐EGFR antibody plus chemotherapy changes toxicity: grade 3 or 4 diarrhoea compared with chemotherapy alone (very low certainty).

2 findings from 1 review

Anti‐EGFR antibody plus chemotherapy vs chemotherapy alone

Grade ≥ 3 diarrhoea · treatment of relapsed epithelial ovarian cancer

It is very uncertain whether anti‐EGFR antibody plus chemotherapy changes toxicity: grade 3 or 4 diarrhoea ‐ seribantumab compared with chemotherapy alone (very low certainty).

1 finding from 1 review

Anti‐EGFR antibody plus chemotherapy vs chemotherapy alone

Toxicity: grade 3 or 4 nausea ± vomiting · treatment of relapsed epithelial ovarian cancer

Anti‐EGFR antibody plus chemotherapy showed no clear difference in toxicity: grade 3 or 4 nausea ± vomiting compared with chemotherapy alone (low certainty).

1 finding from 1 review